Orienting to Results & Collective Efforts

Orienting to Results & Collective
Efforts
Working as a State to
address a complex
problem
Sharing a summary of
the recommendations
by the 2016 Summit by
Track
Governor’s Prescription
Drug Abuse Summit
Held in August, 2016
2-Day Event
Over 450 persons
from across the
Nevada attended to
inform strategies and
recommendations
Recommendations Made in
Four Interrelated Tracks
Collective Impact: 5 Essential Elements
Common agenda
Common agenda
Shared measurement
Shared measurement
Mutually reinforcing activities
Mutually reinforcing activities
Continuous communication
Continuous communication
Backbone support
Backbone support
1.
Design and Implement Data Driven
Collaborative Systems for Decision-Making
to Address the Crisis
2.
Implement Public Awareness to
Educate, Inform, and Engage the Public,
Prescribers, Physicians, and Community-
Based Organizations About the Crisis
3.
Ensure Sufficient Infrastructure and
Resources to Address the Crisis
Summit Cross Cutting Themes
How We Will Get There:
Recommendations from the Summit
Enhanced
Infrastructure
and Resources
Funding and Resource Inputs
Data Driven
Systems
Education
and
Awareness
Cross Cutting
Themes
Policy Changes
Collaboration
Leveraging What’s Working Nationally & In Nevada
A.
Prescribing Guidelines
B.
Prescriber Education
C.
Discharge Planning & Procedures
D.
Oversight of Pain Management Clinics
Track 1: Prescriber
Education &
Guidelines
Components to be included:
Utilize CDC guidelines and adapt them to meet
Nevada’s needs
Incorporate close monitoring, and ensure that
guidelines extend beyond prescribers to pharmacists
Guidelines need to be developed/adopted in alignment
with provider competency requirements
Examine lessons learned from Washington and other
States that have adopted guidelines to determine what
limitations and referral practices need to be in place
Look at Washington guidelines related to referral
practices
Prescribing Guidelines
Adoption of prescribing mandates:
The adoption of prescribing guidelines needs to
support – rather than supersede – the clinical
management of individual patients
Patient needs related to pain management and
addiction treatment need to be distinct in the way
they are described, defined and treated
Medicaid, MCO’s and third party payers need to be
actively involved in implementation design
Prescribing Guidelines
Considerations need to be made related to multiple facets of a
patient’s story – including stage of life, individual history and
circumstance, functioning, and whether pain is acute or
chronic
Prescribers need reimbursement policies that align with
guidelines and allow sufficient time for patient counseling and
education
Adopted guidelines need to undergo regular revision to
remain relevant, evidence-based and responsive to the needs
of Nevada’s culture
Prior to adoption, 100% of licensed prescribers should have
the opportunity to review and provide feedback
Prescribing Guidelines
Prescriber Training:
The science behind pain management (including
genetic and social influencers) and alternative
methods to treatment
A “hands on” approach to integrated care, where
pain is viewed in the context of other specialties and
other disciplines (psychologists, psychiatrists, social
worker)
Address provider-patient
relationship/communication, including empathy
skills
Patient assessment/risk assessment
Prescriber Education
Curriculum and Continuing Education
Adoption of a “whole person” approach: When
talking about pain, there is no one size fits all
Trauma-informed care
Weaning, substitution, effect of age on
medications, psychosocial dynamics,
appropriateness of medications at various
stages of pain management
Prescriber Education
Curriculum and Continuing Education
o
Need curriculum and CME based on CDC guidelines/NV
guidelines to be adopted
o
Evidence-based education/training guidelines need to
be uniform across related disciplines
Implementation of the (ECHO model™) hub-
and-spoke knowledge-sharing network and
learning community to educate and support
clinicians to provide excellent specialty care
to patients in their own communities
Prescriber Education
Adopt a multidisciplinary approach to discharge
planning that includes social workers, RNs, and
referral providers
Initiate MAT prior to discharge, as appropriate
Define the role of pharmacists in discharge plan,
following 2015 guidelines of the College of
Psychiatric and Neurologic Pharmacists
Ensure that behavioral health issues are assessed
and addressed in discharge plan
Discharge Planning and
Procedures
Ensure that ER providers and staff have up-to-date
resource information for warm-hand offs to
supportive services
Provide overdose death and hospital data back to the
prescribing clinician (link PDMP to hospital and death
data)
Ensure that information needed for successful
transitions in care is provided, including Naloxone
administration and response, and collateral
information from involved by-standers
Electronic bed capacity 
inventory
 for
referral/transfer to SUD/BH treatment
Discharge Planning and
Procedures
EMS and criminal investigation teams that
respond to an overdose:
o
Implement overdose response teams
that work in partnership with recovery
communities
Use PDMP to flag patients who have been
treated for overdose
Discharge Planning and
Procedures
No consensus on how pain management clinics
are, and should be, defined.  Consensus on these
recommendations:
Involve medical board, pharmacy board, and other
prescriber licensing boards to determine how pain
clinics are defined
Tie oversight to non-punitive education on guidelines
for all prescribers and staff
Incorporate review of how pain management
specialists classify themselves in terms of board
certification in the oversight process
Pain Management Clinics
A.
Opioid Management
B.
Coverage for Non Opioid Pain Management
Therapies
C.
Early Intervention
D.
Overdose Education & Naloxone Distribution
Track 2: Treatment
Options & Third Party
Payers
Opioid Management
Unprecedented access to prescription drugs has led to
an increased need for medication assisted treatment
through opioid treatment programs.
Nevada should adopt guidelines for comprehensive
opioid treatment management across all payers
Guidelines should be developed by reviewing what
other states/systems have already developed around
this issue and creating a customized version for
Nevada
Guidelines should be established by a multidisciplinary
team
Opioid Management
Address Medicaid Barriers
Billing for MAT is sometimes problematic as
there are not clearly understood billing codes
Develop a Medicaid approved provider options
in rural parts of the state
Reduce payment and administrative barriers to
Medicaid
Opioid Management
Address Access Barriers
Expand access to MAT within the criminal justice
field (institutions, parole, and after-care settings),
including providing support to those that are
homeless
Utilize existing policies (ex: suboxone waiver) to
expand access to MAT – this will require outreach to
qualified providers and revised payment structure
Eliminate barriers such as fail first
Opioid Management
Address Access Barriers
Address workforce shortage issues (especially in the
rural areas) and expand alternative service options
such as telemedicine and mobile units
Ensure patient centered care which allows the full
range of service options to meet each patient’s
needs
Incentivize care coordination through appropriate
payment structure
Non-Opioid Treatment
Management
A wide range of non-opioid treatment options* should be made
available to meet the unique needs of each patient.  If forced to
prioritize therapies, options which should be offered include:
o
Chiropractic
o
Acupuncture
o
Cognitive Behavioral Health
Each of these therapies should be clearly defined to
communicate what kinds of care within each therapy are covered
Therapies offered should be supported by evidence-based
results of success
*
15 options identified at the summit
Non-Opioid Treatment
Management
Enhance provider education, training and experience
which would support non-opioid treatment delivery
Behavioral Health Providers need to understand the role
they could play in pain management services
Physicians need to know what non-opioid pain
management services exist and how to connect patients
to those resources
Address the dis-incentives associated with physicians
“prescribing” non-opioid treatment options (disposition
of clientele, client dissatisfaction, time associated with
treatment option which is not adequately reimbursed)
Non-Opioid Treatment
Management
Increase educational component to
training/licensing about the variety of therapy
options available which support pain management
Need to develop a multidisciplinary team to support
Medicaid and solution implementation
Need to address compounding treatment/recovery
factors such as housing and transportation
Early Intervention
Expand Use of SBIRT among providers and with
complimentary professionals
Encourage/require physicians issue screenings
Embed screenings into electronic health records and
provide training to support utilization
Pharmacist directed SBIRT
Establish a statewide forum for sharing best practice
information on SBIRT and integrated care
Early Intervention
Use behavioral health tele-medicine within
primary care settings/clinics who can conduct
SBIRT and other behavioral health services
Address federal regulations that limit
communication efforts between behavioral health
and primary health care professionals
Resource directory geared towards health
professionals about community resources
available to patients (Healthiernv.org)
Look at IMPACT model out of University of WA
Access to Care
Expand telemedicine options
Address transportation barriers
Case coordination needs to be provided as a
component of comprehensive care.  Peer
leadership models also promote access to care
Partner with existing providers (trusted
community resources – like schools) to act as an
access point
Access to Care
Partner (with Universities) to secure resources and
implement mobile services in rural areas
Examine Rural Veteran’s Programs in Oregon and
Washington as potential models for increasing
access to care in rural areas
Use of community health workers as a component
of care
Overdose Education &
Naloxone Distribution
Reach priority groups for education and distribution
Expand access to Naloxone:
o
Make multiple naloxone doses available to
individuals who have been prescribed Naloxone so
that multiple family members have it available.
o
Enable over the counter access to anyone wanting
Naloxone.
o
Ensure that treatment providers have access to
Naloxone (homeless/substance abuse programs)
Ensure training and education is available to everyone
who may administer naloxone.
A.
Prescription Drug Monitoring Program
B.
Empowerment of Nevada's Occupational
Licensing Boards
C.
Law Enforcement Data Sharing
D.
Public Health Data
Track 3: Data
Collection &
Intelligence Sharing
Ensure Health Insurance Portability and
Accountability Act (HIPAA) compliance between data
systems
Ensure a mechanism for State Boards to report back
to PDMP
Facilitate access to lock in health plans
Mandate providers receiving state dollars sign up to
submit data in PDMP and make this a requirement of
licensing
Evaluate requiring a second signature for
prescription/pain specialists/behaviorists
PDMP
Boards all agree they need to do more and have
been working more collaboratively. They are
crafting language for a bill draft and need
Legislative support to:
Shorten the time frame to obtain records and
lengthen check in to a 60-day dispensing
license
Facilitate access to medical records for
investigation
Empowering
Licensing Boards
Address the issue of phantom prescribers, who
are licensees not on the books
Boards will engage in a unified public awareness
campaign general public, practitioners, and
pharmacists
The Boards have agreed to a website for
anonymous complaints about prescribers or any
health care practitioner
Identify trends, doctor shop by using PDMP
Empowering
Licensing Boards
Use a Fusion Center to model reports using de-
identified data on trends (Look at New
Hampshire model for their partnership with
public health, law enforcement, etc.)
Create centralized data center with the technical
expertise and resources for analyzing and
extracting information specific to the
partners’/communities’ needs. Ensure data is
complete, accurate, and useful, adheres to
HIPAA and other privacy standards
Data (Joint Session on Law
Enforcement Data Sharing)
Use data to drive policy and resource
decisions; and help direct investigations.
Data includes:
Addiction analysis data
Prescriber/payer data
Coroner data re: over dose deaths
Examine what the Drug Enforcement
Administration (DEA) is doing in Clark
County and expand it statewide.
Data (Joint Session on Law
Enforcement Data Sharing)
Utilize coroners, PDMP, and Public Health as a
starting place to establish an agreement for
data sharing
Improve timeliness and distribution of data
(e.g., death records, hospital over doses,
Emergency Medical Services/Fire data re:
overdoses and naloxone distribution, etc.)
Add local health departments into the
information sharing partnerships
Data (Joint Session on Law
Enforcement Data Sharing)
Evaluate feasibility of implementing a dashboard
(in development through DPBH)
There is a need for both identified and de-
identified data and agreements about how data is
collected and reported
Work with coroners to improve the reporting their
data related to overdoses
Collect data from PDMP, and Public Health
including local health districts and workforce data
Use predictive analytics for best practice
identification and public education
Public Health Data
Promote use of the Health Insurance Exchange
(HIE) to obtain more/better data with greater
participation
Integrate data system and reporting consistently,
so data sets ask the same question across
multiples systems
Use memorandums of understanding (MOU) to
put formal data sharing agreements into place
Utilize shared resources across state systems to
strengthen data collection and sharing
Allow access for research and evaluation
Public Health Data
A.
Deterrents for Criminal Activity
B.
Prescription Drug Disposal
C.
Law Enforcement Data Sharing
D.
Sequential Intercept Model
Track 4: Criminal
Justice Interventions
Amend Nevada Statute to mimic federal
thresholds for trafficking Schedule 1 substances 
Lower thresholds for determining felony
classes (suggested levels: 4 to less than 12
grams – C felony, 12- 28 grams – B felony, 28
grams or more – A felony)
In addition to changes in weights, determine
number of pills and lowered pill quantity
Deterrents for
Criminal Activity
Expand penalties – conspiracy is a C felony
and considered too low
Enhance penalties for medical/other
professional provider convicted of crime
[related to opioids]
Allow aggregation in order to
demonstrate/prosecute conspiracy; expand
penalties for conspiracy
Deterrents for
Criminal Activity
Suggested approaches to expand law
enforcement partnerships and data access to
better target over-prescribers,
traffickers/criminal include:
o
Develop policies and procedures for using PDMP
database to send alerts and help investigate
overprescribing. Could use National Crime
Information Center (NCIC) policies/procedures as
example
o
Add state and local partners to participate on the
DEA task force to connect cross state trafficking
Deterrents for
Criminal Activity
Suggested approaches to expand law
enforcement partnerships and data access
(con’t)
o
Build on and formalize partnerships between
agencies, provide a single point of contact for
each agency.  Use the High Intensity Drug
Trafficking Area program (HIDTA) framework.
Formalize how executive supervisors
communicate
Deterrents for
Criminal Activity
Nevada has a robust year-round prescription drug
take back program that is run through the State’s
many prevention coalitions. Nevada has struggled to
find a sustainable solution for prescription drug
disposal
There was agreement that Nevada should adopt a
statewide strategy for sustainable, effective drug
disposal
A variety of disposal options and suggested policies
and practices were outlined for future evaluation
Drug  Disposal
Covered under Track 3: Data Collection and Intelligence
Sharing
Law Enforcement
Data Sharing
Promote successful implementation of SIM
Leverage Certified Community Behavioral
Health Clinics (CCBHCs)
Leverage presumptive eligibility opportunities
for enrollment and Targeted Case
Management (TCM)
Certified peer mentors/navigators
Sequential Intercept
Model (SIM)
Thank You!
More Information about the Summit:
Contact Information
Social Entrepreneurs Inc. 775.324.4567
Project Contact: 
kmarschall@socialent.com
 or 
sboxx@socialent.com
http://gov.nv.gov/uploadedFiles/govnvgov/Conten
t/News_and_Media/RX/FinalSummitReport.pdf
Slide Note

This basic structure helps us to map and organize efforts; but this structure is imperfect – we are in a system that has emerging parts

Time to orient you to information and recommendations – note that we have provided a handout that summarizes information from the summit and more detail available using the link

Embed
Share

Recommendations from the 2016 Governor's Prescription Drug Abuse Summit in Nevada focused on collective efforts to tackle the crisis. Strategies in treatment options, prescriber education, data collection, and criminal justice interventions were highlighted. Cross-cutting themes emphasized data-driven decision-making and public awareness. The summit proposed enhancing infrastructure, education, data systems, funding, policy changes, and collaboration to address the issue effectively.

  • Prescription drug abuse
  • Summit recommendations
  • Collective efforts
  • Data-driven strategies
  • Public awareness

Uploaded on Feb 12, 2025 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. Orienting to Results & Collective Efforts Working as a State to address a complex problem Sharing a summary of the recommendations by the 2016 Summit by Track

  2. Governors Prescription Drug Abuse Summit Held in August, 2016 2-Day Event Over 450 persons from across the Nevada attended to inform strategies and recommendations

  3. Recommendations Made in Four Interrelated Tracks Track 2: Treatment Options & Third-Party Payers Track 1: Prescriber Education & Guidelines Track 3: Data Collection & Intelligence Sharing Track 4: Criminal Justice Interventions

  4. Collective Impact: 5 Essential Elements Common agenda Shared measurement Mutually reinforcing activities Continuous communication Backbone support

  5. Summit Cross Cutting Themes 1. Design and Implement Data Driven Collaborative Systems for Decision-Making to Address the Crisis 2. Implement Public Awareness to Educate, Inform, and Engage the Public, Prescribers, Physicians, and Community- Based Organizations About the Crisis 3. Ensure Sufficient Infrastructure and Resources to Address the Crisis

  6. How We Will Get There: Recommendations from the Summit Enhanced Infrastructure and Resources Education and Awareness Data Driven Systems Funding and Resource Inputs Policy Changes Leveraging What s Working Nationally & In Nevada Collaboration

  7. 1 Track 1: Prescriber Education & Guidelines A.Prescribing Guidelines B.Prescriber Education C.Discharge Planning & Procedures D.Oversight of Pain Management Clinics

  8. 1A Prescribing Guidelines Components to be included: Utilize CDC guidelines and adapt them to meet Nevada s needs Incorporate close monitoring, and ensure that guidelines extend beyond prescribers to pharmacists Guidelines need to be developed/adopted in alignment with provider competency requirements Examine lessons learned from Washington and other States that have adopted guidelines to determine what limitations and referral practices need to be in place Look at Washington guidelines related to referral practices

  9. 1A Prescribing Guidelines Adoption of prescribing mandates: The adoption of prescribing guidelines needs to support rather than supersede the clinical management of individual patients Patient needs related to pain management and addiction treatment need to be distinct in the way they are described, defined and treated Medicaid, MCO s and third party payers need to be actively involved in implementation design

  10. 1A Prescribing Guidelines Considerations need to be made related to multiple facets of a patient s story including stage of life, individual history and circumstance, functioning, and whether pain is acute or chronic Prescribers need reimbursement policies that align with guidelines and allow sufficient time for patient counseling and education Adopted guidelines need to undergo regular revision to remain relevant, evidence-based and responsive to the needs of Nevada s culture Prior to adoption, 100% of licensed prescribers should have the opportunity to review and provide feedback

  11. 1B Prescriber Education Prescriber Training: The science behind pain management (including genetic and social influencers) and alternative methods to treatment A hands on approach to integrated care, where pain is viewed in the context of other specialties and other disciplines (psychologists, psychiatrists, social worker) Address provider-patient relationship/communication, including empathy skills Patient assessment/risk assessment

  12. 1B Prescriber Education Curriculum and Continuing Education Adoption of a whole person approach: When talking about pain, there is no one size fits all Trauma-informed care Weaning, substitution, effect of age on medications, psychosocial dynamics, appropriateness of medications at various stages of pain management

  13. 1B Prescriber Education Curriculum and Continuing Education o Need curriculum and CME based on CDC guidelines/NV guidelines to be adopted o Evidence-based education/training guidelines need to be uniform across related disciplines Implementation of the (ECHO model ) hub- and-spoke knowledge-sharing network and learning community to educate and support clinicians to provide excellent specialty care to patients in their own communities

  14. Discharge Planning and Procedures 1C Adopt a multidisciplinary approach to discharge planning that includes social workers, RNs, and referral providers Initiate MAT prior to discharge, as appropriate Define the role of pharmacists in discharge plan, following 2015 guidelines of the College of Psychiatric and Neurologic Pharmacists Ensure that behavioral health issues are assessed and addressed in discharge plan

  15. Discharge Planning and Procedures 1C Ensure that ER providers and staff have up-to-date resource information for warm-hand offs to supportive services Provide overdose death and hospital data back to the prescribing clinician (link PDMP to hospital and death data) Ensure that information needed for successful transitions in care is provided, including Naloxone administration and response, and collateral information from involved by-standers Electronic bed capacity inventory for referral/transfer to SUD/BH treatment

  16. Discharge Planning and Procedures 1C EMS and criminal investigation teams that respond to an overdose: oImplement overdose response teams that work in partnership with recovery communities Use PDMP to flag patients who have been treated for overdose

  17. 1D Pain Management Clinics No consensus on how pain management clinics are, and should be, defined. Consensus on these recommendations: Involve medical board, pharmacy board, and other prescriber licensing boards to determine how pain clinics are defined Tie oversight to non-punitive education on guidelines for all prescribers and staff Incorporate review of how pain management specialists classify themselves in terms of board certification in the oversight process

  18. 2 Track 2: Treatment Options & Third Party Payers A. Opioid Management B. Coverage for Non Opioid Pain Management Therapies C. Early Intervention D. Overdose Education & Naloxone Distribution

  19. 2A Opioid Management Unprecedented access to prescription drugs has led to an increased need for medication assisted treatment through opioid treatment programs. Nevada should adopt guidelines for comprehensive opioid treatment management across all payers Guidelines should be developed by reviewing what other states/systems have already developed around this issue and creating a customized version for Nevada Guidelines should be established by a multidisciplinary team

  20. 2A Opioid Management Address Medicaid Barriers Billing for MAT is sometimes problematic as there are not clearly understood billing codes Develop a Medicaid approved provider options in rural parts of the state Reduce payment and administrative barriers to Medicaid

  21. 2A Opioid Management Address Access Barriers Expand access to MAT within the criminal justice field (institutions, parole, and after-care settings), including providing support to those that are homeless Utilize existing policies (ex: suboxone waiver) to expand access to MAT this will require outreach to qualified providers and revised payment structure Eliminate barriers such as fail first

  22. 2A Opioid Management Address Access Barriers Address workforce shortage issues (especially in the rural areas) and expand alternative service options such as telemedicine and mobile units Ensure patient centered care which allows the full range of service options to meet each patient s needs Incentivize care coordination through appropriate payment structure

  23. Non-Opioid Treatment Management 2 B A wide range of non-opioid treatment options* should be made available to meet the unique needs of each patient. If forced to prioritize therapies, options which should be offered include: o Chiropractic o Acupuncture o Cognitive Behavioral Health Each of these therapies should be clearly defined to communicate what kinds of care within each therapy are covered Therapies offered should be supported by evidence-based results of success *15 options identified at the summit

  24. Non-Opioid Treatment Management 2 B Enhance provider education, training and experience which would support non-opioid treatment delivery Behavioral Health Providers need to understand the role they could play in pain management services Physicians need to know what non-opioid pain management services exist and how to connect patients to those resources Address the dis-incentives associated with physicians prescribing non-opioid treatment options (disposition of clientele, client dissatisfaction, time associated with treatment option which is not adequately reimbursed)

  25. 2 B Non-Opioid Treatment Management Increase educational component to training/licensing about the variety of therapy options available which support pain management Need to develop a multidisciplinary team to support Medicaid and solution implementation Need to address compounding treatment/recovery factors such as housing and transportation

  26. 2 C Early Intervention Expand Use of SBIRT among providers and with complimentary professionals Encourage/require physicians issue screenings Embed screenings into electronic health records and provide training to support utilization Pharmacist directed SBIRT Establish a statewide forum for sharing best practice information on SBIRT and integrated care

  27. 2 C Early Intervention Use behavioral health tele-medicine within primary care settings/clinics who can conduct SBIRT and other behavioral health services Address federal regulations that limit communication efforts between behavioral health and primary health care professionals Resource directory geared towards health professionals about community resources available to patients (Healthiernv.org) Look at IMPACT model out of University of WA

  28. 2 C Access to Care Expand telemedicine options Address transportation barriers Case coordination needs to be provided as a component of comprehensive care. Peer leadership models also promote access to care Partner with existing providers (trusted community resources like schools) to act as an access point

  29. 2 C Access to Care Partner (with Universities) to secure resources and implement mobile services in rural areas Examine Rural Veteran s Programs in Oregon and Washington as potential models for increasing access to care in rural areas Use of community health workers as a component of care

  30. Overdose Education & Naloxone Distribution 2D Reach priority groups for education and distribution Expand access to Naloxone: o Make multiple naloxone doses available to individuals who have been prescribed Naloxone so that multiple family members have it available. o Enable over the counter access to anyone wanting Naloxone. o Ensure that treatment providers have access to Naloxone (homeless/substance abuse programs) Ensure training and education is available to everyone who may administer naloxone.

  31. Track 3: Data Collection & Intelligence Sharing 3 3 A. Prescription Drug Monitoring Program B. Empowerment of Nevada's Occupational Licensing Boards C. Law Enforcement Data Sharing D. Public Health Data

  32. 3 A PDMP Ensure Health Insurance Portability and Accountability Act (HIPAA) compliance between data systems Ensure a mechanism for State Boards to report back to PDMP Facilitate access to lock in health plans Mandate providers receiving state dollars sign up to submit data in PDMP and make this a requirement of licensing Evaluate requiring a second signature for prescription/pain specialists/behaviorists

  33. Empowering Licensing Boards 3 B Boards all agree they need to do more and have been working more collaboratively. They are crafting language for a bill draft and need Legislative support to: Shorten the time frame to obtain records and lengthen check in to a 60-day dispensing license Facilitate access to medical records for investigation

  34. Empowering Licensing Boards 3 B Address the issue of phantom prescribers, who are licensees not on the books Boards will engage in a unified public awareness campaign general public, practitioners, and pharmacists The Boards have agreed to a website for anonymous complaints about prescribers or any health care practitioner Identify trends, doctor shop by using PDMP

  35. Data (Joint Session on Law Enforcement Data Sharing) 3 C Use a Fusion Center to model reports using de- identified data on trends (Look at New Hampshire model for their partnership with public health, law enforcement, etc.) Create centralized data center with the technical expertise and resources for analyzing and extracting information specific to the partners /communities needs. Ensure data is complete, accurate, and useful, adheres to HIPAA and other privacy standards

  36. Data (Joint Session on Law Enforcement Data Sharing) 3 C Use data to drive policy and resource decisions; and help direct investigations. Data includes: Addiction analysis data Prescriber/payer data Coroner data re: over dose deaths Examine what the Drug Enforcement Administration (DEA) is doing in Clark County and expand it statewide.

  37. Data (Joint Session on Law Enforcement Data Sharing) 3 C Utilize coroners, PDMP, and Public Health as a starting place to establish an agreement for data sharing Improve timeliness and distribution of data (e.g., death records, hospital over doses, Emergency Medical Services/Fire data re: overdoses and naloxone distribution, etc.) Add local health departments into the information sharing partnerships

  38. 3 D Public Health Data Evaluate feasibility of implementing a dashboard (in development through DPBH) There is a need for both identified and de- identified data and agreements about how data is collected and reported Work with coroners to improve the reporting their data related to overdoses Collect data from PDMP, and Public Health including local health districts and workforce data Use predictive analytics for best practice identification and public education

  39. 3 D Public Health Data Promote use of the Health Insurance Exchange (HIE) to obtain more/better data with greater participation Integrate data system and reporting consistently, so data sets ask the same question across multiples systems Use memorandums of understanding (MOU) to put formal data sharing agreements into place Utilize shared resources across state systems to strengthen data collection and sharing Allow access for research and evaluation

  40. Track 4: Criminal Justice Interventions 4 A. Deterrents for Criminal Activity B. Prescription Drug Disposal C. Law Enforcement Data Sharing D. Sequential Intercept Model

  41. 4 A Deterrents for Criminal Activity Amend Nevada Statute to mimic federal thresholds for trafficking Schedule 1 substances Lower thresholds for determining felony classes (suggested levels: 4 to less than 12 grams C felony, 12- 28 grams B felony, 28 grams or more A felony) In addition to changes in weights, determine number of pills and lowered pill quantity

  42. 4 A Deterrents for Criminal Activity Expand penalties conspiracy is a C felony and considered too low Enhance penalties for medical/other professional provider convicted of crime [related to opioids] Allow aggregation in order to demonstrate/prosecute conspiracy; expand penalties for conspiracy

  43. 4 A Deterrents for Criminal Activity Suggested approaches to expand law enforcement partnerships and data access to better target over-prescribers, traffickers/criminal include: o Develop policies and procedures for using PDMP database to send alerts and help investigate overprescribing. Could use National Crime Information Center (NCIC) policies/procedures as example o Add state and local partners to participate on the DEA task force to connect cross state trafficking

  44. 4 A Deterrents for Criminal Activity Suggested approaches to expand law enforcement partnerships and data access (con t) o Build on and formalize partnerships between agencies, provide a single point of contact for each agency. Use the High Intensity Drug Trafficking Area program (HIDTA) framework. Formalize how executive supervisors communicate

  45. 4 B Drug Disposal Nevada has a robust year-round prescription drug take back program that is run through the State s many prevention coalitions. Nevada has struggled to find a sustainable solution for prescription drug disposal There was agreement that Nevada should adopt a statewide strategy for sustainable, effective drug disposal A variety of disposal options and suggested policies and practices were outlined for future evaluation

  46. Law Enforcement Data Sharing 4 C Covered under Track 3: Data Collection and Intelligence Sharing

  47. Sequential Intercept Model (SIM) 4 D Promote successful implementation of SIM Leverage Certified Community Behavioral Health Clinics (CCBHCs) Leverage presumptive eligibility opportunities for enrollment and Targeted Case Management (TCM) Certified peer mentors/navigators

  48. Thank You! More Information about the Summit: http://gov.nv.gov/uploadedFiles/govnvgov/Conten t/News_and_Media/RX/FinalSummitReport.pdf Contact Information Social Entrepreneurs Inc. 775.324.4567 Project Contact: kmarschall@socialent.com or sboxx@socialent.com

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#